Women are set to benefit from employers taking robust action on the gender pay gap and menopause support, as the Minister for ...

Cambridge2Cambridge transatlantic company Mursla Bio is building on its US presence with its nextgen liver cancer ...

The Employment Rights Act 2025 will strengthen unfair dismissal protection for employees by reducing the length of service ...

Despite a marginal positive shift at CEO level, overall representation of women in leadership positions in UK biotech have stalled according to the BioIndustry Association’s report, Women in Biotech ...

At a time when investors debate the wisdom of investing in artificial intelligence (AI), a much-cited annual report issues a timely reminder: while investors often associate hot new technologies with ...

Reflecting on the Chancellor’s Spring Statement, it was clear that this was largely an opportunity to explain the direction of the economy; making the Government’s case as to why their plan is the ...

Law firm Mills & Reeve advised on an over-subscribed seed extension investment round for Microneedle Solutions (MNS), which will enable the company to advance its Miracus™ needle-free patch platform ...

Oxford Business Park company, Oxa, has revealed a successful first close of its Series D funding round, raising a total of $103 million. A second and final Series D close is expected in H1 2026.

Last year, the Government announced a cash injection of £102 million of capital funding for bricks and mortar upgrades within GP-based healthcare services. It’s a healthcare space in which BTG ...

A new Google DeepMind Academic Fellowship is to be hosted at the Wellcome Sanger Institute in Cambridge, exploring the application of artificial intelligence (AI) in genomics through a ...

Arm has entered into a strategic partnership with Danantara Indonesia, the sovereign investment institution of the Republic ...

AIM-listed specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, has promoted ...